Radius Takes $91MM To Support Osteoporosis Drug, Moves Toward Public Listing
This article was originally published in The Pink Sheet Daily
Executive Summary
Five new investors back the owner of anabolic bone therapy BA058, while a reverse merger paves the way to the public markets.